Skip to content
Disclosery

ORBIMED ADVISORS LLC: ABVX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on ABVX, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 546,522 ABVX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 546,522 shares
    Change vs previous 13F +80,822 shares

    1.38% of the 13F portfolio, value $72,829,522.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 465,700 shares
    Change vs previous 13F +97,800 shares

    1.13% of the 13F portfolio, value $51,855,695.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 367,900 shares
    Change vs previous 13F -12,100 shares

    1.02% of the 13F portfolio, value $49,613,155.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 380,000 shares
    Change vs previous 13F not available

    0.77% of the 13F portfolio, value $32,262,000.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).